Cargando…
Dysbiosis in SARS-CoV-2–Infected Patients
Autores principales: | Marazzato, Massimiliano, Ceccarelli, Giancarlo, d’Ettorre, Gabriella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the AGA Institute
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773314/ https://www.ncbi.nlm.nih.gov/pubmed/33387514 http://dx.doi.org/10.1053/j.gastro.2020.12.056 |
Ejemplares similares
-
Diet Supplementation, Probiotics, and Nutraceuticals in SARS-CoV-2 Infection: A Scoping Review
por: Infusino, Fabio, et al.
Publicado: (2020) -
Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary Therapeutic Strategy to Avoid the Progression of COVID-19
por: d'Ettorre, Gabriella, et al.
Publicado: (2020) -
Fr576 ORAL BACTERIOTHERAPY IN PATIENTS WITH COVID-19: A RETROSPECTIVE COHORT STUDY
por: Marazzato, Massimiliano, et al.
Publicado: (2021) -
The non-functional ACE2 isoform, but not the SARS-CoV-2 receptor, is induced as an interferon-stimulated gene, in SARS-CoV-2 infected adults
por: Oliveto, Giuseppe, et al.
Publicado: (2022) -
SARS-CoV-2 related paediatric acute-onset neuropsychiatric syndrome
por: Pavone, Piero, et al.
Publicado: (2021)